Clinical research group Icon has reported strong results for the first quarter of 2008 and lifted its forecasts for the rest of the year.
Net revenue jumped by 48% compared with Q1 2007 to $201.3, while net profits were just under $17m, compared with $12.3m a year earlier.
Diluted earnings per share were up 33% to 56 cents, and Icon said it won a record $369m worth of new business in the quarter.
The company said it was raising its forecast for full-year revenue to $840m to $860m, while it now expected earnings per share of $2.35 to $2.45.
Icon shares closed up €1.95 at €43 in Dublin.
